1.Perforated Choledochal Cyst with Bile Peritonitis in an Infant.
Sang Geel LEE ; Yen Hee KANG ; Ki Chang HAN ; Su Sang SHON
Journal of the Korean Pediatric Society 1982;25(8):854-858
A case report of a perforated choledochal cyst with bile peritonitis occurring in a 13-month old girl is presented. The perfortion was identified on the right lateral aspect of the common bile duct. And T-tube drainage was instituted. Episodes of ascending cholangitis followed pooling of the stagnant bile in the biliary system. Reoperation was recommended but in vain.
Bile*
;
Biliary Tract
;
Cholangitis
;
Choledochal Cyst*
;
Common Bile Duct
;
Drainage
;
Female
;
Humans
;
Infant*
;
Peritonitis*
;
Reoperation
2.Azidothymidine and recombinant human interferon-alpha therapy in a cat with feline immunodeficiency virus.
Hye Jin JANG ; Yen Kang HO ; Min Hee KANG ; Seung Gon KIM ; Woo Jung PARK ; In Soo CHOI ; Dae Young KIM ; Hee Myung PARK
Journal of Biomedical Research 2014;15(2):96-99
A 7-year-old, spayed female, domestic short hair cat showed signs of a 2-week history of chronic anorexia, depression, and severe weight loss. Upon physical examination, pyrexia, mild gingivitis, and pale mucus membranes were noted. Laboratory analysis revealed normocytic normochromic non-regenerative anemia, severe thrombocytopenia, and hypergammaglobulinemia. Serum protein electrophoresis revealed the presence of elevated alpha-2 fraction within the globulin concentration. Based on history, clinical signs, and laboratory results, systemic viral infection was strongly suspected. Reverse transcriptase polymerase chain reaction identified the presence of feline immunodeficiency virus (FIV) in the serum. Furthermore, gene sequencing revealed the virus as FIV subtype A. Treatment with anti-retroviral agents, including azidothymidine (AZT) and recombinant human interferon-alpha, was continued for 4 weeks. However, the patient's clinical condition deteriorated, resulting in death 1 month after initiation of treatment due to progressive renal failure. Necropsy and histopathology revealed hepatic and renal necrosis with hyper-cellular bone marrow mainly comprised of myeloid precursor cells. This case report is the first to describe phylogenetic subtyping, anti-retroviral combination treatment, and clinical outcomes in an FIV-infected cat in Korea. In addition, this report suggests that treatment should be initiated during the early phase of infection that could be effective for the virus.
Anemia
;
Animals
;
Anorexia
;
Anti-Retroviral Agents
;
Bone Marrow
;
Cats*
;
Child
;
Depression
;
Electrophoresis
;
Female
;
Fever
;
Gingivitis
;
Hair
;
Humans
;
Hypergammaglobulinemia
;
Immunodeficiency Virus, Feline*
;
Interferon-alpha*
;
Korea
;
Membranes
;
Mucus
;
Necrosis
;
Physical Examination
;
Renal Insufficiency
;
Reverse Transcriptase Polymerase Chain Reaction
;
Thrombocytopenia
;
Weight Loss
;
Zidovudine*
3.IGF-I and -II production during menstrual cycle.
Jae Yen SONG ; Ji Sun WEE ; Hyun Jung CHO ; Ill Young KOOK ; Hyun Hee JO ; Mee Ran KIM ; Dong Jin KWON ; Chang Suk KANG ; Jang Heub KIM
Korean Journal of Obstetrics and Gynecology 2006;49(7):1515-1526
OBJECTIVE: We designed this study to understand the physiologic effects and secretory pattern of IGF-I and IGF-II in human serum and changes in expression of IGF-I and IGF-II in human ovarian tissues during menstrual cycle, and to know which one is more important on human ovarian function between IGF-I and IGF-II, related to FSH, LH and estradiol. METHODS: IGF-I, IGF-II, FSH, LH and estradiol levels were measured in 80 serum samples by ELISA from normal reproductive women. We also examined the immunohistochemical staining of the IGF-I and IGF-II in the ovarian tissues of 14 normal reproductive women. The mean age was 35.6+/-9.15 years-old, ranged from 20 to 45. The average menstrual cycle was 27 to 29 days. RESULTS: 1. The average serum concentration of IGF-I was 204.43+/-50.92 ng/mL, and that of IGF-II was 1381.56+/-292.56 ng/mL. 2. The regular pattern or relationship on serum IGF-I and IGF-II concentrations were not observed (P=0.19). 3. To cross-correlation of serum concentrations of FSH, LH, estradiol and IGF-I, IGF-II, IGF-II was thought to effect on human ovarian menstrual cycles, affected by action of FSH (P=0.048). 4. In the normal reproductive ovaries, we observed immunohistochemical staining for IGF-I in primary, secondary, mature follicle, corpus luteum and stroma, but not in corpus albicans. 5. In the normal reproductive ovaries, we observed immunohistochemical staining for IGF-II in primary, secondary, mature follicle, and corpus luteum but not in corpus albicans and stroma. 6. Stronger immunohistochemical staining was observed in ovaries for IGF-II, rather than IGF-I. CONCLUSION: IGF-I and IGF-II were produced by ovarian tissues, and participated in ovarian folliculogenesis according to menstrual cycles by paracrine, autocrine functions. IGF-II, rather than IGF-I, was thought to effect greater on human ovarian menstrual cycles, affected by action of FSH.
Corpus Luteum
;
Enzyme-Linked Immunosorbent Assay
;
Estradiol
;
Female
;
Humans
;
Immunohistochemistry
;
Insulin-Like Growth Factor I*
;
Insulin-Like Growth Factor II
;
Menstrual Cycle*
;
Ovarian Follicle
;
Ovary